New book by Larry Connors Click here Improve your trading - See how
-- Jun 29, 2009 CytRx Corporation (NASDAQ:CYTR) closed at $0.95 on a volume of 2,859,519 shares.
CytRx Files Report with the FDA in Response to the Partial Clinical Hold on its Phase 2b Arimoclomol ALS Trial
LOS ANGELES, Jun 30, 2009 -- CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, has filed a report with the U.S. Food and Drug Administrations (FDA) in response to the Agency's partial clinical hold on the Company's Phase 2b efficacy clinical trial with its molecular chaperone regulator drug candidate arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
About CytRx Corporation
CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The CytRx drug development pipeline includes programs in clinical development for cancer indications, including tamibarotene in a registration study for the treatment of acute promyelocytic leukemia (APL). In addition, CytRx is developing two drug candidates based on its industry-leading molecular chaperone technology, which aims to repair or degrade misfolded proteins associated with disease. The Company owns and operates a research and development facility in San Diego. CytRx also maintains a 45% equity interest in publicly traded RXi Pharmaceuticals, Inc. (NASDAQ:RXII). For more information on the Company, visit www.cytrx.com.
-- Jun 29, 2009 Activision Publishing, Inc. (Nasdaq: ATVI | Quote | Chart | News | PowerRating) closed at $12.71 on a volume of 7,526,138 shares.
Ice Age(TM): Dawn of the Dinosaurs Video Game Hits Store Shelves Worldwide Today
Activision and Twentieth Century Fox Licensing & Merchandising Deliver an Exciting New Game Where Kids Control Their Favorite Sub-Zero Heroes in an All New Adventure
SANTA MONICA, Calif., June 30, 2009 -- It's time for gamers around the world to embark on an all-new incredible adventure with their favorite sub-zero heroes in Ice Age(TM): Dawn of the Dinosaurs from Activision Publishing, Inc. (Nasdaq: ATVI | Quote | Chart | News | PowerRating) and Twentieth Century Fox Licensing & Merchandising (Fox Licensing). Based on the highly anticipated 3-D animated feature from Twentieth Century Fox, which debuts worldwide on July 1, the game allows players to command their favorite movie characters, including Sid, Manny, Diego, Scrat and the relentless one-eyed Dino hunting weasel, Buck, and venture into a mysterious underground world of dinosaurs, while solving puzzles and platforming through more than 15 exciting levels.
Activision Publishing maintains operations in the U.S., Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, Norway, Denmark, the Netherlands, Australia, Russia, Japan, South Korea, China and the region of Taiwan. More information about Activision and its products can be found on the company's website, www.activision.com.
-- Jun 26, 2009 POZEN Inc. (NASDAQ:POZN) closed at $8.22 on a volume of 284,987 shares.
POZEN Submits New Drug Application For VIMOVO(TM) (PN 400)
CHAPEL HILL, N.C., Jun 30, 2009 -- POZEN Inc. (NASDAQ:POZN), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO(TM) (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. POZEN and AstraZeneca entered into a global co-development agreement for VIMOVO in August 2006. Pending regulatory approval, the proposed trade name is VIMOVO and the proposed indications are for the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk for developing NSAID-associated ulcers.
About POZEN
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for Treximet(R), which was approved in 2008 by the United States Food and Drug Administration for the acute treatment of migraine attacks, with or without aura, in adults, and with AstraZeneca for VIMOVO(TM), a proprietary fixed dose combination of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The Company's common stock is traded on The NASDAQ Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website:www.pozen.com.
-- Jun 29, 2009 Silicon Motion Technology Corporation (Nasdaq:SIMO) closed at $3.76 on a volume of 131,867 shares.
Silicon Motion Announces Flash Controllers Supporting Micron 34 nm MLC Flash
TAIPEI, Taiwan, Jun 30, 2009 -- Silicon Motion Technology Corporation (Nasdaq:SIMO) (the "Company"), a leading fabless semiconductor company that designs, develops and markets semiconductor solutions for multimedia consumer electronics, today announced that Micron Technology, Inc. has validated the Company's latest flash controllers for use with Micron's 34-nanometer multi-level cell (MLC) flash product family. The products include its new 16 gigabit (Gb) and 32Gb parts announced today. The validated Silicon Motion products include SM2682/SM2682LT SD controllers, SM2232/SM2234 CF controllers, SM2235/SM2242 SSD controllers, and SM3251/SM3252 USB flash drive (UFD) controllers, all of which are in mass production.
About Silicon Motion:
We are a fabless semiconductor company that designs, develops and markets high performance, low-power semiconductor solutions for the multimedia consumer electronics market. We have three major product lines: mobile storage, mobile communications, and multimedia SoCs. Our mobile storage business is composed of microcontrollers used in NAND flash memory storage products such as flash memory cards, USB flash drives, SSDs, embedded flash applications, and card readers. Our mobile communications business is composed of mobile TV IC solutions, CDMA RF ICs, and electronic toll collection RF ICs. Our multimedia SoCs business is composed of products that support portable multimedia players, DAB systems, PC cameras, and embedded graphics applications.
-- Jun 29, 2009 Cadence Design Systems, Inc. (NASDAQ: CDNS | Quote | Chart | News | PowerRating) closed at $6.09 on a volume of 3,093,385 shares.
Hitachi Achieves 40% Reduction in PCB Place-and-Route Design Time With Cadence Global Route Environment
Hitachi's Deployment of Allegro Global Route Environment Technology Significantly Streamlines PCB Design Process
SAN JOSE, CA, Jun 30, 2009 -- Cadence Design Systems, Inc. (NASDAQ: CDNS), the leader in global electronic design innovation, today announced that the Cadence(R) Global Route Environment (GRE) technology for Cadence Allegro(R) PCB design enabled Hitachi, Ltd. to successfully reduce printed circuit board (PCB) place-and-route design time by 40% for a high-speed communication product. Hitachi applied the GRE place-and-route design methodology to its PCB place-and-route from interconnect planning to complete routing, with full constraints for high-speed digital signals where no automation was previously available. The time-saving results were reported by Hitachi Communication Technologies, Ltd., the communication products division of Hitachi Group, as part of a companywide initiative at Hitachi to enhance design efficiency and reduce design-cycle time.
About Cadence
Cadence enables global electronic design innovation and plays an essential role in the creation of today's integrated circuits and electronics. Customers use Cadence software and hardware, methodologies, and services to design and verify advanced semiconductors, consumer electronics, networking and telecommunications equipment, and computer systems. The company is headquartered in San Jose, Calif., with sales offices, design centers, and research facilities around the world to serve the global electronics industry. More information about the company, its products, and services is available at www.cadence.com.
-- Jun 29, 2009 Electronic Arts Inc. (NASDAQ:ERTS) closed at $20.81 on a volume of 3,535,209 shares.
Maloof Money Cup Makes Its Videogame Debut in the Critically Acclaimed Skate 2
Compete in the World's Greatest Skateboarding Event with Skate 2's Latest Downloadable Content
REDWOOD CITY, Calif., Jun 30, 2009 -- Electronic Arts Inc. (NASDAQ:ERTS) announced today that starting July 9 gamers can download and compete in Skate 2's Maloof Money Cup Pack, based on the largest pursed event in the history of professional skateboarding. The pack will be available in the PLAYSTATION(R) Store for $3.00 and on Xbox LIVE(R) Marketplace for 240 points in North America.
About Electronic Arts
Electronic Arts Inc. (EA), headquartered in Redwood City, California, is a leading global interactive entertainment software company. Founded in 1982, the Company develops, publishes, and distributes interactive software worldwide for video game systems, personal computers, wireless devices and the Internet. Electronic Arts markets its products under four brand names: EA(TM), EA SPORTS(TM), EA Mobile(TM) and POGO(TM). In fiscal 2009, EA posted GAAP net revenue of $4.2 billion and had 31 titles that sold more than one million copies. EA's homepage and online game site is www.ea.com. More information about EA's products and full text of press releases can be found on the Internet at http://info.ea.com.
About PennyStockChaser.com
PennyStockChaser.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, new 52 weeks high or lows, stocks with technical indicators and much more. Our stock alerts have done very well in the last couple of weeks.
PennyStockChaser.com is a leading stock website that provides free daily alerts on stocks that are moving up. PennyStockChaser.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at editorial@pennystockchaser.com
PennyStockChaser.com is an independent electronic publication that provides information on selected publicly traded companies. PennyStockChaser.com is not a registered investment advisor or broker-dealer. PennyStockChaser.com's affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
CONTACT: Editorial Staff, PennyStockChaser e-mail: editorial@pennystockchaser.com WWW: http://www.pennystockchaser.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
